Kossel Medtech Subsidiary Haiyu Xincheng Receives NMPA Approval for Cathvenus® Disposable Adjustable Loop Pulmonary Vein Mapping Catheter

Recently, Cathvenus®, a disposable adjustable loop pulmonary vein mapping catheter independently developed by Haiyu Xincheng, a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., located in the Jiangsu Medical Device Technology Park (Medpark), has been approved for marketing by the National Medical Products Administration (NMPA).

Atrial fibrillation (AF) is a common arrhythmia in clinical practice, characterized by the disappearance of regular and orderly atrial electrical activity, which is replaced by rapid and disordered fibrillation waves. It represents a severe form of atrial electrical disturbance. This condition not only affects the normal function of the heart but also increases the risk of thrombosis and stroke. Data shows that the prevalence of AF rises with age, and among people over 80 years old, the proportion of AF patients exceeds 10%. AF can increase all-cause mortality in the population by 1.5 to 3.5 times, imposing significant health impacts and economic burdens on patients and their families. It has become a global public health issue that urgently needs to be addressed.

The circular pulmonary vein mapping catheter is one of the indispensable mapping catheters in atrial fibrillation surgery. The Cathvenus® disposable adjustable bend circular pulmonary vein mapping catheter, composed of an O-ring, a tube body, and a handle, is used for mapping, recording pulmonary vein electrical signals, or performing pacing stimulation. The product offers various fixed distal loop diameter options to accommodate different sizes of pulmonary veins, enabling rapid and precise modeling and capturing more anatomical details.

The launch of Cathvenus® disposable adjustable loop pulmonary vein mapping catheter further enhances the safety and effectiveness of atrial fibrillation surgery, contributing to the development of China's electrophysiology field.

Kossel's subsidiary, Suzhou Haiyu Xincheng, is committed to the mission of "developing excellent products, serving human health, and benefiting more patients." It focuses on the field of cardiac electrophysiology, aiming to provide comprehensive solutions for the diagnosis and treatment of tachyarrhythmia, and is dedicated to contributing to the development of China's cardiac electrophysiology industry!

Medpark is a national-level medical device science and technology industrial park co-built by Suzhou New District and the Suzhou Institute of Biomedical Engineering Technology of the Chinese Academy of Sciences. It is responsible for coordinating the resources of Suzhou New District, relying on three core capabilities: "carrier development and construction + park operation + industrial investment". It focuses on the development of the medical device industry and strives to build itself into a high-end medical device industry highland with uniqueness, leadership, and标志性.

Currently, the industrial park's products cover fields such as medical imaging, biomedical materials, in vitro diagnostics, and medical robotics, with numerous technological achievements being the first of their kind in China and leading the industry.

Since its establishment more than ten years ago, Medpark has successively received national honorary titles such as the National Torch Plan Medical Device Special Industry Base, the Pilot Project of the National Innovative Medical Device Industry Cluster, the National Medical Device Professional Incubator, and the Demonstration Unit for the Construction of the National Technology Entrepreneurship Incubation Chain.